Enantiomer (-) of tenatoprazole and the therapeutic use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 26, 2010
Grant Date -
Aug 31, 2006
app pub date -
Feb 1, 2006
filing date -
Dec 16, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to enantiomer (−) of tentoprazole. The inventive enantiomer (−) of tenatoprazole, or (−)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazol[4,5-b]pyridine exhibits improved pharmacokinetic properties which make it possible to use a once a day posology of a drug for relevant indications. The enantiomer (−) of tentoprazole can be used for treating digestive pathologies.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully